Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

U Shinde

Showing results (31-40 of 45) with videos related to

Pageof 5
Sort By:
Nutrition Journal|March 22, 2013
Maternal dietary intake of nitrates, nitrites and nitrosamines and selected birth defects in offspring: a case-control studyJohn C Huber, Jean D Brender, Qi Zheng, et al.
Pharmacoepidemiology and Drug Safety|September 18, 2024
Exposure to Valsartan Products Containing Nitrosamine Impurities in the United States, Canada, and DenmarkEfe Eworuke, Mayura U Shinde, Laura Hou, et al.
Pharmacoepidemiology and Drug Safety|April 2, 2024
Validity of inpatient electronic health record-based measures of oxygen-related therapy in the United States: Lessons applicable for studying COVID-19 endpointsCandace C Fuller, Edward Rosen, Ashish Rai, et al.
Birth Defects Research. Part A, Clinical and Molecular Teratology|May 30, 2013
Prenatal exposure to nitrosatable drugs, vitamin C, and risk of selected birth defectsMayura U Shinde, Ann M Vuong, Jean D Brender, et al.
American Journal of Epidemiology|March 9, 2016
Prenatal Exposure to Nitrosatable Drugs, Dietary Intake of Nitrites, and Preterm BirthAnn M Vuong, Mayura U Shinde, Jean D Brender, et al.
American Journal of Epidemiology|November 4, 2011
Nitrosatable drug exposure during early pregnancy and neural tube defects in offspring: National Birth Defects Prevention StudyJean D Brender, Martha M Werler, Katherine E Kelley, et al.
Birth Defects Research. Part A, Clinical and Molecular Teratology|August 21, 2012
Nitrosatable drug exposure during the first trimester of pregnancy and selected congenital malformationsJean D Brender, Martha M Werler, Mayura U Shinde, et al.
Paediatric and Perinatal Epidemiology|December 11, 2014
Nitrosatable Drug Exposure during Pregnancy and Preterm and Small-for-Gestational-Age BirthsAnn M Vuong, Mayura U Shinde, Jean D Brender, et al.
Pharmacoepidemiology and Drug Safety|April 14, 2026
Identifying COVID-19 Disease Severity in Real-World Data: Implications for Medical Product Effectiveness StudiesMayura U Shinde, Katherine Shapiro, Laura Hou, et al.
Bioorganic & Medicinal Chemistry Letters|September 11, 2022
Discovery of MDV6058 (PF-06952229), a selective and potent TGFβR1 inhibitor: Design, synthesis and optimizationBrahmam Pujala, Sreekanth A Ramachandran, Mukesh Sonawane, et al.
Pageof 5

Showing results (31-40 of 45) with videos related to

Sort By:
Pageof 5
Nutrition Journal|March 22, 2013
Maternal dietary intake of nitrates, nitrites and nitrosamines and selected birth defects in offspring: a case-control studyJohn C Huber, Jean D Brender, Qi Zheng, et al.
Pharmacoepidemiology and Drug Safety|September 18, 2024
Exposure to Valsartan Products Containing Nitrosamine Impurities in the United States, Canada, and DenmarkEfe Eworuke, Mayura U Shinde, Laura Hou, et al.
Pharmacoepidemiology and Drug Safety|April 2, 2024
Validity of inpatient electronic health record-based measures of oxygen-related therapy in the United States: Lessons applicable for studying COVID-19 endpointsCandace C Fuller, Edward Rosen, Ashish Rai, et al.
Birth Defects Research. Part A, Clinical and Molecular Teratology|May 30, 2013
Prenatal exposure to nitrosatable drugs, vitamin C, and risk of selected birth defectsMayura U Shinde, Ann M Vuong, Jean D Brender, et al.
American Journal of Epidemiology|March 9, 2016
Prenatal Exposure to Nitrosatable Drugs, Dietary Intake of Nitrites, and Preterm BirthAnn M Vuong, Mayura U Shinde, Jean D Brender, et al.
American Journal of Epidemiology|November 4, 2011
Nitrosatable drug exposure during early pregnancy and neural tube defects in offspring: National Birth Defects Prevention StudyJean D Brender, Martha M Werler, Katherine E Kelley, et al.
Birth Defects Research. Part A, Clinical and Molecular Teratology|August 21, 2012
Nitrosatable drug exposure during the first trimester of pregnancy and selected congenital malformationsJean D Brender, Martha M Werler, Mayura U Shinde, et al.
Paediatric and Perinatal Epidemiology|December 11, 2014
Nitrosatable Drug Exposure during Pregnancy and Preterm and Small-for-Gestational-Age BirthsAnn M Vuong, Mayura U Shinde, Jean D Brender, et al.
Pharmacoepidemiology and Drug Safety|April 14, 2026
Identifying COVID-19 Disease Severity in Real-World Data: Implications for Medical Product Effectiveness StudiesMayura U Shinde, Katherine Shapiro, Laura Hou, et al.
Bioorganic & Medicinal Chemistry Letters|September 11, 2022
Discovery of MDV6058 (PF-06952229), a selective and potent TGFβR1 inhibitor: Design, synthesis and optimizationBrahmam Pujala, Sreekanth A Ramachandran, Mukesh Sonawane, et al.
Pageof 5